Abstract Early health technology assessment (early HTA) is a useful tool in guiding the innovation development process in medical technology development. However, the application of early HTA is sub-optimal amongst research and development (R&D) communities due to several challenges. In this pa

Abstract Objective: The National Health Security Office in Thailand introduced a telemedicine program called “Telehealth/Telemedicine” in December 2020, which aimed to reimburse telemedicine services for patients with stable chronic diseases under the Universal Coverage Scheme (UCS). The current

Highlights Economic evidence (cost-effectiveness information) can be used to inform policy-making process in supporting the movement towards universal health coverage. Published literature has focused on methods to set a cost-effectiveness threshold (CET) which can be used to guide the cost-eff

Abstract Introduction The COVID-19 pandemic highlighted the significance of mathematical modelling in decision-making and the limited capacity in many low-income and middle-income countries (LMICs). Thus, we studied how modelling supported policy decision-making processes in LMICs during the pand

Abstract Background and Objectives The Health Intervention and Technology Assessment Program was commissioned to conduct a cost–utility and budget impact analysis of enzyme replacement therapy (ERT) for Gaucher disease types 1 and 3b. The findings from this assessment are to support the decision-m

Abstract Background Systems thinking approaches can determine system interdependencies to guide effective policymaking but have been underutilised in health policymaking, particularly for policies related to access and delivery of health services. In Thailand, a policy changing access to dialysi

In this paper we have reported a five-stage process, including a two-round Delphi survey that developed and reached consensus on a definition of early HTA, which is “a health technology assessment conducted to inform decisions about subsequent development, research and/or investment by explicitly ev

Naiyana Praditsitthikorn BSc(Pharm), PhD*,** * Health Intervention and Technology Assessment Program, Ministry of Public Health, Nonthaburi, Thailand ** Bureau of AIDS TB and STIs, Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand There is an increasing number of at

Usa Chaikledkaew BSc(Pharm), MA, PhD*,** * Social and Administrative Pharmacy Excellence Research (SAPER) Unit, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand ** Health Intervention and Technology Assessment Program, Ministry of Public Health, Nonthaburi, Thail

Keywords: Health technology assessment, Rationale, Guideline development   Please follow the link below for full text. You may need to register (free-of-charge) as the article is published in Journal of the Medical Association of Thailand, Vol 91, No 6. http://www.jmatonline.com/index.